Advancements in medical research, including silicon nanowires and stem cell cardiomyocytes, offer potential breakthroughs in repairing damaged hearts, fostering hope for cardiac regeneration
Read MoreA new study investigates coffee consumption's influence on abdominal aortic calcification (AAC) incidence, scrutinizing adults with hypertension, diabetes, and cardiovascular disease (CVD) alongside healthy counterparts.
Read MoreThe FDA grants approval to INJECTAFER, heralding a game-changer in the treatment of iron deficiency among adult heart failure patients.
Read MoreA major breakthrough in heart failure treatment occurs as the FDA granted its approval for sotagliflozin (Inpefa), marking a significant milestone in cardiac care, providing renewed hope for patients and healthcare providers alike
Read MoreNew and compelling research presented at EHRA 2023, the European Society of Cardiology (ESC) scientific congress, has unveiled the potential benefits of statins in reducing stroke risks and transient ischemic attacks (TIA) in patients diagnosed with atrial fibrillation (AF)
Read MoreResearch has illuminated the longevity-linked form of the BPIFB4 gene (LAV) as linked to extended human lifespans and defensive impacts against cardiovascular disease in animal models. Recent findings indicate LAV-BPIFB4's potential in fostering blood vessel growth and countering cellular senescence, contributing to cardioprotection
Read MoreNew research indicates that elevated uric acid levels during midlife can substantially increase the likelihood of developing a severe form of irregular heartbeat in later decades, even among individuals devoid of conventional risk factors
Read MoreDespite current guidelines discouraging its use, a recent study reveals that many older adults continue to take a daily baby aspirin to prevent first-time heart problems.
Read MoreA recent study explored the impact of canagliflozin on individuals dealing with both type 2 diabetes and the risks associated with heart disease.
Read More